Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2005
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680370A Epothilones C, and its preparation and use as cell inhibitor
10/12/2005CN1680342A Diazosulfide derivative and its synthesis and screening method for inducing anti-disease activity
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1222524C Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222511C I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953790 CGRP receptor antagonists
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2282277C Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092885A1 4-amino-piperidine derivatives as monoamine uptake inhibitors
10/06/2005WO2005092881A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092863A1 4-carbox pyrazole derivates useful as anti-viral agents
10/06/2005WO2005092856A1 Tetrahydrocarbazoles and derivatives
10/06/2005WO2005092855A1 Process for cross coupling indoles
10/06/2005WO2005092304A2 Antifungal agents
10/06/2005WO2005092099A1 Hiv integrase inhibitors
10/06/2005WO2005075471A3 Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222424 Phenyloxyalkanonic acid derivatives as hppar activators
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222408 Administering to a tuberculosis patient a therapeutically effective amount of N-(4-methoxybenzyl)-5-nitrofuran-2-carboxamide or other derivatives of heterocyclic amides
10/06/2005US20050222236 Viral polymerase inhibitors
10/06/2005US20050222230 3,4-diarylpyrazoles and their use in the therapy of cancer
10/06/2005US20050222226 N-[3-(2-Aminoethyl)-4-(4-bromophenyl)thiazol-2(3H)-ylidene]aniline; antiinflammatory agents, antiallergens; inhibit infiltration of leukocytes such as eosinophils and lymphocytes; autoimmune diseases, asthma
10/06/2005US20050222223 And oxazole sulfonamides: 3-(2-{1-[(4-Chloro-benzenesulfonyl)-(2,5-difluoro-phenyl)-amino]-ethyl}-thiazol-5-yl)-propionic acid; Alzheimer's disease, hereditary cerebral hemorrhage with amyloidosis, cerebral amyloid angiopathy, prion-mediated disease, inclusion body myositis, stroke, multiple sclerosis
10/06/2005US20050222222 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
10/06/2005US20050222220 GSK-3 inhibitors
10/06/2005US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
10/06/2005US20050222215 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2005US20050222206 Pyridinoylpiperidines as 5-ht1f agonists
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222186 Substituted diaminopyrimidines
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222159 2,3-dihydropyridazin-3-ones e.g. 3-amino-6-(1-isopropyl-6-oxo-1,6-dihydro-3-pyridazinyl)-5-phenyl-2-pyrazinecarboxamide; adenosine antagonists; depression, dementia, Parkinson's disease, anxiety, pain, hypertension, obesity, gout, bronchial asthma
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222149 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222141 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050222047 Compounds as enzyme inhibitors to treat hepatitis with viricides
10/06/2005US20050221989 O-cyclopropyl-carboxanilides and their use as fungicides
10/06/2005DE102004012901A1 Silylierte Carboxamide Silylated carboxamides
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2557785A1 Hiv integrase inhibitors
10/06/2005CA2552980A1 Process for cross coupling indoles
10/05/2005EP1581536A2 Epothilone derivatives
10/05/2005EP1581529A1 Benzoxazines and derivatives thereof as inhibitors of pi3ks
10/05/2005EP1581528A1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
10/05/2005EP1581527A2 Thrombopoietin mimetics
10/05/2005EP1581526A1 Benzisoxazole derivatives useful as inhibitors of protein kinases
10/05/2005EP1581525A2 Compounds having an activity at metabotropic glutamate receptors
10/05/2005EP1581523A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581518A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581517A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581515A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581503A2 Ophthalmic compositions for treating ocular hypertension
10/05/2005EP1581501A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581261A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
10/05/2005EP1581229A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
10/05/2005EP1581222A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
10/05/2005EP1581218A1 Epothilone analogs for site specific delivery in the treatment of proliferative diseases
10/05/2005EP1581217A1 Carbonylamino-benzimidazole derivatives as androgen receptor modulators
10/05/2005EP1581214A1 4,5-diarylthiazole derivatives as cb-1 ligands
10/05/2005EP1581207A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005CN1678620A Macrolide compounds endowed with antiinflammatory activity
10/05/2005CN1678613A Hetereoaryl nitrile derivatives
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678597A Novel quaternary ammonium compounds
10/05/2005CN1678596A Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678593A Microbiocidal (e.g. fungicidal) 1, 2, 3-triazole derivatives
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678311A Aryl carbonyl derivatives as therapeutic agents
10/05/2005CN1678306A -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
10/05/2005CN1221548C Oxazolidinones having sulfoximine functional group
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 628